SCHEMBL1709600

SCHEMBL1709600

O=C(Nc1ccc(Br)cn1)C(Cc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.56
HDAC3 O15379 3/20 0.56
HDAC4 P56524 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
HDAC6 Q9UBN7 2/20 0.56
HDAC2 Q92769 2/20 0.52
HDAC10 Q969S8 2/20 0.52
HDAC11 Q96DB2 2/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
NPC1 O15118 3/20 0.50
ALDH1A1 P00352 4/20 0.49
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL934062 0.99 HDAC1 (0.55) HDAC1HDAC3HDAC4HDAC8HDAC6
Hydrochloric Acid SCHEMBL1286555 0.99 HDAC1 (0.55) HDAC1HDAC3HDAC4HDAC8HDAC6
SCHEMBL1709568 0.85 RAB9A (0.55) HDAC1HDAC3HDAC4HDAC8HDAC6
SCHEMBL10097905 0.85 L3MBTL1 (0.61) HDAC1HDAC3HDAC4HDAC8HDAC6
Hydrochloric Acid SCHEMBL934494 0.84 RAB9A (0.54) HDAC1HDAC3HDAC4HDAC8HDAC6
Hydrochloric Acid SCHEMBL934544 0.84 L3MBTL1 (0.60) HDAC1HDAC3HDAC4HDAC8HDAC6
SCHEMBL1709554 0.81 EP300 (0.53) HDAC1HDAC3HDAC4HDAC8HDAC6
Hydrochloric Acid SCHEMBL933356 0.81 EP300 (0.52) HDAC1HDAC3HDAC4HDAC8HDAC6
SCHEMBL1709574 0.78 RAB9A (0.62) HDAC1HDAC3HDAC4HDAC8HDAC6
Hydrochloric Acid SCHEMBL933189 0.77 RAB9A (0.61) HDAC1HDAC3HDAC4HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS ALLERGAN, INC. (US) 2012-04-12 US disclosed
WO-2011008475-A1 OPTIONALLY SUBSTITUTED 2-(ARYLMETHYL, ARYLOXY OR ARYLTHIO) -N- PYRIDIN-2 -YL-ARYL ACETAMIDE OR 2, 2-BIS (ARYL) -N-PYRIDIN-2-YL ACETAMIDE COMPOUNDS AS MEDICAMENTS FOR THE TREATMENT OF EYE DISEASES ALLERGAN, INC. (US) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS S1PR3, S1PR5, S1PR1 HDAC1 3460/4885HDAC3 2341/4885HDAC4 2817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.